| vosoritide 0.56 MG Injection [Voxzogo] vosoritide | 23 | 0.5%
| T4 | 100% | - |
| vosoritide 1.2 MG Injection [Voxzogo] vosoritide | 23 | 0.5%
| T4 | 100% | - |
| amlodipine 1 MG/ML Oral Suspension [Katerzia] amlodipine | 22 | 0.4%
| T3 | 0% | 11,575,402 |
| famotidine 26.6 MG / ibuprofen 800 MG Oral Tablet famotidine | 22 | 0.4%
| T2 | 100% | 3,593,191 |
| clindamycin phosphate 0.012 MG/MG / tretinoin 0.00025 MG/MG Topical Gel clindamycin phosphate | 22 | 0.4%
| T3 | 100% | 303,687 |
| diflorasone diacetate 0.5 MG/ML Topical Cream diflorasone diacetate | 22 | 0.4%
| T3 | 0% | 6,653 |
| tazarotene 1 MG/ML Topical Foam tazarotene | 22 | 0.4%
| T3 | 75% | 4,869 |
| adapalene 1 MG/ML Medicated Pad adapalene | 22 | 0.4%
| T3 | 100% | 4,155 |
| secnidazole 2000 MG Oral Granules [Solosec] secnidazole | 22 | 0.4%
| T4 | 25% | 167 |
| acetaminophen 300 MG / butalbital 50 MG / caffeine 40 MG Oral Capsule [Fioricet] acetaminophen | 22 | 0.4%
| T2 | 50% | 156 |
| gefitinib 250 MG Oral Tablet [Iressa] gefitinib | 22 | 0.4%
| T3 | 100% | 90 |
| Emollient clobetasol propionate 0.5 MG/ML Topical Foam [Tovet] Emollient clobetasol propionate | 22 | 0.4%
| T4 | 0% | - |
| zolpidem tartrate 10 MG Sublingual Tablet [Edluar] zolpidem tartrate | 21 | 0.4%
| T4 | 0% | 1,435,449 |
| zolpidem tartrate 5 MG Sublingual Tablet [Edluar] zolpidem tartrate | 21 | 0.4%
| T4 | 0% | 1,435,449 |
| chlorthalidone 12.5 MG Oral Tablet [Hemiclor] chlorthalidone | 21 | 0.4%
| T4 | 0% | 783,324 |
| acyclovir 50 MG/ML / hydrocortisone 10 MG/ML Topical Cream [Xerese] acyclovir | 21 | 0.4%
| T5 | 0% | 670,065 |
| lamotrigine 100 MG Disintegrating Oral Tablet [Lamictal] lamotrigine | 21 | 0.4%
| T4 | 0% | 611,083 |
| lamotrigine 200 MG Disintegrating Oral Tablet [Lamictal] lamotrigine | 21 | 0.4%
| T4 | 0% | 611,083 |
| halobetasol propionate 0.1 MG/ML / tazarotene 0.45 MG/ML Topical Lotion [Duobrii] halobetasol propionate | 21 | 0.4%
| T5 | 100% | 89,868 |
| nepafenac 1 MG/ML Ophthalmic Suspension [Nevanac] nepafenac | 21 | 0.4%
| T3 | 0% | 28,476 |
| tazarotene 0.45 MG/ML Topical Lotion [Arazlo] tazarotene | 21 | 0.4%
| T4 | 100% | 4,869 |
| tazarotene 1 MG/ML Topical Foam [Fabior] tazarotene | 21 | 0.4%
| T4 | 100% | 4,869 |
| fingolimod 0.25 MG Oral Capsule [Gilenya] fingolimod | 21 | 0.4%
| T4 | 60% | 2,875 |
| benzoyl peroxide 0.0375 MG/MG / clindamycin phosphate 0.012 MG/MG Topical Gel [Onexton] benzoyl peroxide | 21 | 0.4%
| T4 | 0% | 465 |
| hydrocortisone acetate 25 MG/ML / pramoxine hydrochloride 10 MG/ML Topical Lotion [Pramosone] hydrocortisone acetate | 21 | 0.4%
| T4 | 0% | 430 |
| hydrocortisone acetate 10 MG/ML / pramoxine hydrochloride 10 MG/ML Topical Lotion [Pramosone] hydrocortisone acetate | 21 | 0.4%
| T4 | 0% | 430 |
| 24 HR doxazosin 4 MG Extended Release Oral Tablet [Cardura] doxazosin | 21 | 0.4%
| T4 | 0% | 166 |
| 24 HR doxazosin 8 MG Extended Release Oral Tablet [Cardura] doxazosin | 21 | 0.4%
| T4 | 0% | 166 |
| mecamylamine hydrochloride 2.5 MG Oral Tablet [Vecamyl] mecamylamine hydrochloride | 21 | 0.4%
| T5 | 0% | - |
| vamorolone 40 MG/ML Oral Suspension [Agamree] vamorolone | 21 | 0.4%
| T4 | 100% | - |
| 1.2 ML somatrogon-ghla 20 MG/ML Pen Injector [Ngenla] somatrogon-ghla | 21 | 0.4%
| T4 | 100% | - |
| 1.2 ML somatrogon-ghla 50 MG/ML Pen Injector [Ngenla] somatrogon-ghla | 21 | 0.4%
| T4 | 100% | - |
| levothyroxine sodium 0.013 MG Oral Capsule levothyroxine sodium | 20 | 0.4%
| T3 | 0% | 8,687,969 |
| levothyroxine sodium 0.112 MG Oral Capsule levothyroxine sodium | 20 | 0.4%
| T3 | 0% | 8,687,969 |
| levothyroxine sodium 0.137 MG Oral Capsule levothyroxine sodium | 20 | 0.4%
| T3 | 0% | 8,687,969 |
| zolmitriptan 2.5 MG Oral Tablet [Zomig] zolmitriptan | 20 | 0.4%
| T2 | 0% | 11,158 |
| zolmitriptan 5 MG Oral Tablet [Zomig] zolmitriptan | 20 | 0.4%
| T2 | 0% | 11,158 |
| estradiol 0.0006 MG/MG Topical Gel [Elestrin] estradiol | 19 | 0.4%
| T4 | 0% | 1,289,816 |
| hydrocortisone 25 MG/ML Topical Solution [Texacort] hydrocortisone | 19 | 0.4%
| T4 | 0% | 1,257,661 |
| sucralfate 100 MG/ML Oral Suspension [Carafate] sucralfate | 19 | 0.4%
| T2 | 0% | 800,942 |
| colchicine 0.5 MG Oral Tablet [Lodoco] colchicine | 19 | 0.4%
| T4 | 100% | 553,640 |
| pazopanib 200 MG Oral Tablet [Votrient] pazopanib | 19 | 0.4%
| T4 | 100% | 1,555 |
| doxycycline hyclate 80 MG Delayed Release Oral Tablet doxycycline hyclate | 18 | 0.4%
| T1 | 0% | 4,121,486 |
| doxycycline hyclate 75 MG Oral Tablet doxycycline hyclate | 18 | 0.4%
| T1 | 0% | 4,121,486 |
| difluprednate 0.5 MG/ML Ophthalmic Suspension [Durezol] difluprednate | 18 | 0.4%
| T2 | 0% | 69,636 |
| flurandrenolide 0.5 MG/ML Topical Lotion flurandrenolide | 18 | 0.4%
| T4 | 0% | 1,839 |
| maraviroc 300 MG Oral Tablet [Selzentry] maraviroc | 18 | 0.4%
| T3 | 0% | 1,674 |
| asenapine 5 MG Sublingual Tablet [Saphris] asenapine | 18 | 0.4%
| T3 | 100% | 714 |
| asenapine 10 MG Sublingual Tablet [Saphris] asenapine | 18 | 0.4%
| T3 | 100% | 714 |
| 30 ACTUAT fluticasone furoate 0.05 MG/ACTUAT Dry Powder Inhaler | 18 | 0.4%
| T2 | 0% | - |
| 30 ACTUAT fluticasone furoate 0.1 MG/ACTUAT Dry Powder Inhaler | 18 | 0.4%
| T2 | 0% | - |
| 30 ACTUAT fluticasone furoate 0.2 MG/ACTUAT Dry Powder Inhaler | 18 | 0.4%
| T2 | 0% | - |
| azithromycin 500 MG Injection [Zithromax] azithromycin | 17 | 0.3%
| T3 | 0% | 5,970,026 |
| nitroglycerin 0.4 MG/ACTUAT Mucosal Spray [Nitrolingual] nitroglycerin | 17 | 0.3%
| T2 | 0% | 1,348,161 |
| lurasidone hydrochloride 20 MG Oral Tablet [Latuda] lurasidone hydrochloride | 17 | 0.3%
| T4 | 33.3% | 97,963 |
| lurasidone hydrochloride 40 MG Oral Tablet [Latuda] lurasidone hydrochloride | 17 | 0.3%
| T4 | 33.3% | 97,963 |
| lurasidone hydrochloride 60 MG Oral Tablet [Latuda] lurasidone hydrochloride | 17 | 0.3%
| T4 | 33.3% | 97,963 |
| lurasidone hydrochloride 80 MG Oral Tablet [Latuda] lurasidone hydrochloride | 17 | 0.3%
| T4 | 33.3% | 97,963 |
| lurasidone hydrochloride 120 MG Oral Tablet [Latuda] lurasidone hydrochloride | 17 | 0.3%
| T4 | 33.3% | 97,963 |
| mesalamine 66.7 MG/ML Enema [Rowasa] mesalamine | 17 | 0.3%
| T3 | 0% | 95,185 |
| dimethyl fumarate 120 MG Delayed Release Oral Capsule [Tecfidera] dimethyl fumarate | 17 | 0.3%
| T4 | 33.3% | 7,901 |
| dimethyl fumarate 240 MG Delayed Release Oral Capsule [Tecfidera] dimethyl fumarate | 17 | 0.3%
| T4 | 33.3% | 7,901 |
| {14 (dimethyl fumarate 120 MG Delayed Release Oral Capsule [Tecfidera]) / 46 (dimethyl fumarate 240 MG Delayed Release Oral Capsule [Tecfidera]) } Pack [Tecfidera 30-Day Starter Pack] dimethyl fumarate | 17 | 0.3%
| T4 | 33.3% | 3,154 |
| fingolimod 0.5 MG Oral Capsule [Gilenya] fingolimod | 17 | 0.3%
| T4 | 33.3% | 2,875 |
| phenylephrine hydrochloride 1 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution phenylephrine hydrochloride | 17 | 0.3%
| T2 | 84.6% | 1,468 |
| 12 HR dalfampridine 10 MG Extended Release Oral Tablet [Ampyra] dalfampridine | 17 | 0.3%
| T4 | 100% | 1,179 |
| emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet [Truvada] emtricitabine | 17 | 0.3%
| T5 | 0% | 997 |
| emtricitabine 100 MG / tenofovir disoproxil fumarate 150 MG Oral Tablet [Truvada] emtricitabine | 17 | 0.3%
| T5 | 0% | 997 |
| emtricitabine 133 MG / tenofovir disoproxil fumarate 200 MG Oral Tablet [Truvada] emtricitabine | 17 | 0.3%
| T5 | 0% | 997 |
| emtricitabine 167 MG / tenofovir disoproxil fumarate 250 MG Oral Tablet [Truvada] emtricitabine | 17 | 0.3%
| T5 | 0% | 997 |
| 3 ML icatibant 10 MG/ML Prefilled Syringe [Firazyr] icatibant | 17 | 0.3%
| T4 | 100% | 213 |
| lonapegsomatropin-tcgd 3 MG Cartridge [Skytrofa] lonapegsomatropin-tcgd | 17 | 0.3%
| T4 | 100% | - |
| lonapegsomatropin-tcgd 3.6 MG Cartridge [Skytrofa] lonapegsomatropin-tcgd | 17 | 0.3%
| T4 | 100% | - |
| lonapegsomatropin-tcgd 4.3 MG Cartridge [Skytrofa] lonapegsomatropin-tcgd | 17 | 0.3%
| T4 | 100% | - |
| lonapegsomatropin-tcgd 5.2 MG Cartridge [Skytrofa] lonapegsomatropin-tcgd | 17 | 0.3%
| T4 | 100% | - |
| lonapegsomatropin-tcgd 6.3 MG Cartridge [Skytrofa] lonapegsomatropin-tcgd | 17 | 0.3%
| T4 | 100% | - |
| lonapegsomatropin-tcgd 7.6 MG Cartridge [Skytrofa] lonapegsomatropin-tcgd | 17 | 0.3%
| T4 | 100% | - |
| lonapegsomatropin-tcgd 9.1 MG Cartridge [Skytrofa] lonapegsomatropin-tcgd | 17 | 0.3%
| T4 | 100% | - |
| lonapegsomatropin-tcgd 11 MG Cartridge [Skytrofa] lonapegsomatropin-tcgd | 17 | 0.3%
| T4 | 100% | - |
| lonapegsomatropin-tcgd 13.3 MG Cartridge [Skytrofa] lonapegsomatropin-tcgd | 17 | 0.3%
| T4 | 100% | - |
| lonapegsomatropin-tcgd 0.7 MG Cartridge [Skytrofa] lonapegsomatropin-tcgd | 17 | 0.3%
| T4 | 100% | - |
| lonapegsomatropin-tcgd 1.4 MG Cartridge [Skytrofa] lonapegsomatropin-tcgd | 17 | 0.3%
| T4 | 100% | - |
| lonapegsomatropin-tcgd 1.8 MG Cartridge [Skytrofa] lonapegsomatropin-tcgd | 17 | 0.3%
| T4 | 100% | - |
| lonapegsomatropin-tcgd 2.1 MG Cartridge [Skytrofa] lonapegsomatropin-tcgd | 17 | 0.3%
| T4 | 100% | - |
| lonapegsomatropin-tcgd 2.5 MG Cartridge [Skytrofa] lonapegsomatropin-tcgd | 17 | 0.3%
| T4 | 100% | - |
| 24 HR viloxazine 100 MG Extended Release Oral Capsule [Qelbree] viloxazine | 16 | 0.3%
| T3 | 33.3% | 2,252 |
| 24 HR viloxazine 150 MG Extended Release Oral Capsule [Qelbree] viloxazine | 16 | 0.3%
| T3 | 33.3% | 2,252 |
| 24 HR viloxazine 200 MG Extended Release Oral Capsule [Qelbree] viloxazine | 16 | 0.3%
| T3 | 33.3% | 2,252 |
| {3 (ponesimod 10 MG Oral Tablet [Ponvory]) / 2 (ponesimod 2 MG Oral Tablet [Ponvory]) / 2 (ponesimod 3 MG Oral Tablet [Ponvory]) / 2 (ponesimod 4 MG Oral Tablet [Ponvory]) / 1 (ponesimod 5 MG Oral Tablet [Ponvory]) / 1 (ponesimod 6 MG Oral Tablet [Ponvory]) / 1 (ponesimod 7 MG Oral Tablet [Ponvory]) / 1 (ponesimod 8 MG Oral Tablet [Ponvory]) / 1 (ponesimod 9 MG Oral Tablet [Ponvory]) } Pack [Ponvory 14 Day] ponesimod | 16 | 0.3%
| T4 | 100% | 99 |
| ponesimod 20 MG Oral Tablet [Ponvory] ponesimod | 16 | 0.3%
| T4 | 100% | 99 |
| {21 (drospirenone 3 MG / ethinyl estradiol 0.03 MG / levomefolate calcium 0.451 MG Oral Tablet) / 7 (levomefolate calcium 0.451 MG Oral Tablet) } Pack [Safyral 28 Day] drospirenone | 16 | 0.3%
| T3 | 0% | - |
| 0.8 ML adalimumab-aacf 50 MG/ML Auto-Injector adalimumab-aacf | 16 | 0.3%
| T4 | 66.7% | - |
| ceftobiprole medocaril sodium 667 MG Injection [Zevtera] ceftobiprole medocaril sodium | 16 | 0.3%
| T4 | 33.3% | - |
| 0.4 ML adalimumab-fkjp 50 MG/ML Prefilled Syringe adalimumab-fkjp | 16 | 0.3%
| T3 | 91.7% | - |
| 0.8 ML adalimumab-fkjp 50 MG/ML Prefilled Syringe adalimumab-fkjp | 16 | 0.3%
| T3 | 91.7% | - |
| 0.8 ML adalimumab-fkjp 50 MG/ML Auto-Injector adalimumab-fkjp | 16 | 0.3%
| T3 | 91.7% | - |
| tafluprost 0.015 MG/ML Ophthalmic Solution [Zioptan] tafluprost | 15 | 0.3%
| T4 | 0% | 15,313 |
| octreotide 20 MG Delayed Release Oral Capsule [Mycapssa] octreotide | 15 | 0.3%
| T4 | 100% | 3,041 |
| citric acid 0.01 MG/MG / lactic acid 0.018 MG/MG / potassium bitartrate 0.004 MG/MG Vaginal Gel [Phexxi] citric acid | 15 | 0.3%
| T4 | 0% | 573 |
| citric acid 0.01 MG/MG / lactic acid 0.018 MG/MG / potassium bitartrate 0.004 MG/MG Vaginal Gel [Phexx] citric acid | 15 | 0.3%
| T4 | 0% | 573 |